PROGRESSIVE NORMALIZATION OF GH BINDING PROTEIN AND IGF₁ PLASMA LEVELS DURING THE FIRST YEAR OF GH THERAPY IN GH-DEFICIENT CHILDREN

Abstract

The short- and long-term effects of GH treatment on GH binding protein (GHBP) were examined in GH deficient children. Ten prepubertal children (6 boys, 4 girls), aged 2-10 yr, with isolated GH deficiency and short stature (SD from normal height = 2.4 ± 1.2) were studied before treatment and at regular intervals during GH therapy (0.50 IU/Kg/week). GHBP was measured by HPLC-gel filtration and correction was made forGH levels > 6 ng/ml. Results of plasma GHBP (% of radioactivity) and IGF_I levels (ng/ml) are expressed as mean ± SEM. Normal values for age are: GHBP = 24.8 ±1.7%, IGF_I = 105 ±10 ng/ml.

The basal GHBP level is low. A significant decrease in GHBP is found 6 h after the first injection of GH. The time of induction of GHBP by GH appears variable: in half of the patients GHBP values arc normalized during the first 6 months of treatment. 100% of the GHBP values are normal after 12 monihs. Mean IGF₁ levels are significantly increased 48 h following the first injection of GH and IGF₁ levels arc normal after 6 months. No correlation was found between ihc plasma levels of GHBP and IGF₁ nor between their increment under GH treatment. In conclusion, low GHBP levels arc found in GH-dcficicnt children. During GH therapy, the progressive increase in IGF₁ levels occurs before the increase in GHBP levels.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account

Continue with Google

Continue with ORCiD